Koya Medical (“Koya”), a medical technology company advancing evidence-based therapies for vascular disease, has announced its participation in two upcoming investor conferences:
Goldman Sachs Healthcare Private Company Conference
Andy Doraiswamy (CEO) will present on Monday, October 19, 2026, at the Goldman Sachs Client Center in New York City.
The MedTech Conference, hosted by AdvaMed®
Damian Rippole (CFO) will present as part of the Bank of America Company Presentations on Tuesday, October 20, 2026, in Room 050 at the Thomas M. Menino Convention & Exhibition Center in Boston.
Doraiswamy and Rippole will highlight the company’s commercial momentum for its vascular portfolio—including Dayspring® non-pneumatic compression treatment for chronic edema—and share progress on its vascular pipeline and ongoing clinical research.
About Koya Medical
Founded in 2018 and headquartered in Dallas, Koya Medical is a medical technology company developing a portfolio of evidence-based treatments designed to improve clinical outcomes and patient experience in vascular disease.
